{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:20:22Z","timestamp":1792300822715,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C1012507"],"award-info":[{"award-number":["2021R1A2C1012507"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["\/KR2023\/003210"],"award-info":[{"award-number":["\/KR2023\/003210"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116856","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T08:03:06Z","timestamp":1726128186000},"page":"116856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of the therapeutic potential of PPAR\u03b4 agonist bearing 1,3,4- thiadiazole in inflammatory disorders"],"prefix":"10.1016","volume":"279","author":[{"given":"Jina","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara Man","family":"Kadayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugyeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungjin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh-bin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Kyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6060-0508","authenticated-orcid":false,"given":"Jungwook","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2024.116856_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.2006.03261.x","article-title":"Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1\u03b2 generation","volume":"147","author":"Ferrero-Miliani","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"No 6","key":"10.1016\/j.ejmech.2024.116856_bib2","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"6785","key":"10.1016\/j.ejmech.2024.116856_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116856_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116856_bib5","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/en.2003-0288","article-title":"Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116856_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbadis.2004.11.011","article-title":"Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes","volume":"1740","author":"Luquet","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116856_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12017-020-08629-9","article-title":"Recent insights on the role of PPAR-\u03b2\/\u03b4 in neuroinflammation and neurodegeneration, and its potential target for therapy","volume":"23","author":"Strosznajder","year":"2021","journal-title":"NeuroMolecular Med."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116856_bib8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116856_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of ppars in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116856_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1165\/rcmb.2005-0289OC","article-title":"Role of prostacyclin versus peroxisome proliferator-activated receptor \u03b2 receptors in prostacyclin sensing by lung fibroblasts","volume":"34","author":"Ali","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"45","key":"10.1016\/j.ejmech.2024.116856_bib11","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.3748\/wjg.v21.i45.12787","article-title":"Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease","volume":"21","author":"Lee","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116856_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00011-007-7157-4","article-title":"Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPAR\u03b2\/\u03b4 ligand GW0742","volume":"57","author":"Haskova","year":"2008","journal-title":"Inflamm. Res."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116856_bib13","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1164\/rccm.201002-0240OC","article-title":"Protective role of peroxisome proliferator\u2013activated receptor-\u03b2\/\u03b4 in septic shock","volume":"182","author":"Kapoor","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"24","key":"10.1016\/j.ejmech.2024.116856_bib14","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1016\/j.bmcl.2010.10.103","article-title":"Selective peroxisome proliferator-activated receptor \u03b4 isosteric selenium agonists as potent anti-atherogenic agents in vivo","volume":"20","author":"Chin","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116856_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2012.03.055","article-title":"Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor \u03b4 agonists as potent anti-obesity agents in vivo","volume":"53","author":"Ham","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2024.116856_bib16","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.bmc.2018.06.044","article-title":"Synthesis and evaluation of an orally available \u201cY\u201d-shaped biaryl peroxisome proliferator-activated receptor \u03b4 agonist","volume":"26","author":"Kim","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116856_bib17","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/acsomega.7b01689","article-title":"Enantioselective synthesis of a novel thiazoline core as a potent peroxisome proliferator-activated receptor \u03b4 agonist","volume":"3","author":"Lee","year":"2018","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116856_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bmcl.2017.11.006","article-title":"Highly selective peroxisome proliferator-activated receptor \u03b4 (PPAR\u03b4) modulator demonstrates improved safety profile compared to GW501516","volume":"28","author":"Lagu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"23","key":"10.1016\/j.ejmech.2024.116856_bib19","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1158\/1078-0432.CCR-16-0775","article-title":"Molecular pathways: dietary regulation of stemness and tumor initiation by the PPAR-\u03b4 pathway","volume":"22","author":"Beyaz","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116856_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113339","article-title":"The role of PPAR-\u03b4 in metabolism, inflammation, and cancer: many characters of a critical transcription factor","volume":"19","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.ejmech.2024.116856_bib23","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1021\/acs.jmedchem.9b01882","article-title":"Targeting peroxisome proliferator-activated receptor delta (PPAR\u03b4): a medicinal chemistry perspective","volume":"63","author":"Kadayat","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116856_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/156802608784535084","article-title":"PPAR modulators and PPAR Pan agonists for metabolic diseases: the next generation of drugs targeting peroxisome proliferator-activated receptors?","volume":"8","author":"Feldman","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116856_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"Sahebkar","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116856_bib26","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.116856_bib27","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1021\/jm070511x","article-title":"Synthesis and identification of [1,2,4]Thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors \u03b1 and \u03b4","volume":"50","author":"Shen","year":"2007","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116856_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11307-015-0830-z","article-title":"Combined fluorescence and magnetic resonance imaging of primary macrophage migration to sites of acute inflammation using near-infrared fluorescent magnetic nanoparticles","volume":"17","author":"Kang","year":"2015","journal-title":"Mol. Imag. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116856_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7150\/thno.17131","article-title":"Visualization of macrophage recruitment to inflammation lesions using highly sensitive and stable radionuclide-embedded gold nanoparticles as a nuclear bio-imaging platform","volume":"7","author":"Lee","year":"2017","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116856_bib30","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1124\/dmd.106.010793","article-title":"Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes","volume":"34","author":"Lu","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116856_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187231211794455235","article-title":"An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS\/MS","volume":"5","author":"Otten","year":"2011","journal-title":"Drug Metabol. Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116856_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11095-007-9517-8","article-title":"A novel design of artificial membrane for improving the PAMPA model","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116856_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2008.137","article-title":"Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach","volume":"6","author":"Piper","year":"2008","journal-title":"Assay Drug Dev. Technol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:06:54Z","timestamp":1777529214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424007372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S0223523424007372"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116856","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of the therapeutic potential of PPAR\u03b4 agonist bearing 1,3,4- thiadiazole in inflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116856"}}